# UL Solutions Inc.: overview

ULS · NYSE · CIK 1901440 · [Industrials](/sectors/industrials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/uls.md) · [Financials](/companies/uls/financials.md) · [Filings](/companies/uls/filings.md) · [Insiders](/companies/uls/insiders.md)

Latest reported revenue: [$816.0m](/filings/0001901440-26-000023.md) for Q2 FY2026, three months to 2026-06-30, from the 10-Q filed Aug 4, 2026 (XBRL us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, accession 0001901440-26-000023).

## Last eight quarters

| Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [731](/filings/0001901440-25-000047.md) | [739 d](/filings/0001901440-26-000005.md) | [705](/filings/0001901440-26-000012.md) | [776](/filings/0001901440-26-000023.md) | [783](/filings/0001901440-25-000047.md) | [789 d](/filings/0001901440-26-000005.md) | [758](/filings/0001901440-26-000012.md) | [816](/filings/0001901440-26-000023.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | [17.8%](/filings/0001901440-25-000047.md) | [15.6% d](/filings/0001901440-26-000005.md) | [15.5%](/filings/0001901440-26-000012.md) | [17.9%](/filings/0001901440-26-000023.md) | [19.9%](/filings/0001901440-25-000047.md) | [15.0% d](/filings/0001901440-26-000005.md) | [18.2%](/filings/0001901440-26-000012.md) | [18.4%](/filings/0001901440-26-000023.md) |
| Net margin | % | [12.0%](/filings/0001901440-25-000047.md) | [11.0% d](/filings/0001901440-26-000005.md) | [9.5%](/filings/0001901440-26-000012.md) | [11.7%](/filings/0001901440-26-000023.md) | [12.8%](/filings/0001901440-25-000047.md) | [8.5% d](/filings/0001901440-26-000005.md) | [12.1%](/filings/0001901440-26-000012.md) | [30.1%](/filings/0001901440-26-000023.md) |
| Diluted EPS | $ per share | [0.44](/filings/0001901440-25-000047.md) | not reported | [0.33](/filings/0001901440-26-000012.md) | [0.45](/filings/0001901440-26-000023.md) | [0.49](/filings/0001901440-25-000047.md) | not reported | [0.45](/filings/0001901440-26-000012.md) | [1.21](/filings/0001901440-26-000023.md) |
| Free cash flow | $m | [84.0 d](/filings/0001901440-25-000047.md) | [72.0 d](/filings/0001901440-26-000005.md) | [103](/filings/0001901440-26-000012.md) | [105 d](/filings/0001901440-26-000023.md) | [109 d](/filings/0001901440-25-000047.md) | [86.0 d](/filings/0001901440-26-000005.md) | [150](/filings/0001901440-26-000012.md) | [91.0 d](/filings/0001901440-26-000023.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure.

## Last five fiscal years

| Line item | Unit | FY (2022-12-31) | FY (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: |
| Revenue | $m | [2,520](/filings/0001901440-25-000012.md) | [2,678](/filings/0001901440-26-000005.md) | [2,870](/filings/0001901440-26-000005.md) | [3,053](/filings/0001901440-26-000005.md) |
| Gross margin | % | not reported | not reported | not reported | not reported |
| Operating margin | % | [16.3%](/filings/0001901440-25-000012.md) | [13.7%](/filings/0001901440-26-000005.md) | [16.1%](/filings/0001901440-26-000005.md) | [17.1%](/filings/0001901440-26-000005.md) |
| Net margin | % | [11.6%](/filings/0001901440-25-000012.md) | [9.7%](/filings/0001901440-26-000005.md) | [11.4%](/filings/0001901440-26-000005.md) | [10.6%](/filings/0001901440-26-000005.md) |
| Diluted EPS | $ per share | [1.47](/filings/0001901440-25-000012.md) | [1.30](/filings/0001901440-26-000005.md) | [1.62](/filings/0001901440-26-000005.md) | [1.60](/filings/0001901440-26-000005.md) |
| Free cash flow | $m | [208](/filings/0001901440-25-000012.md) | [252](/filings/0001901440-26-000005.md) | [287](/filings/0001901440-26-000005.md) | [403](/filings/0001901440-26-000005.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/uls/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $726.4m | 7,131,683 |  | Added +1,682,816 |
| [Capital International Investors](/funds/1562230.md) | 2026-06-30 | $622.9m | 6,115,196 |  | Added +40,930 |
| [KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC](/funds/1021223.md) | 2026-06-30 | $478.2m | 4,694,443 |  | Reduced −704,153 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $357.0m | 3,504,948 |  | Added +48,201 |
| [Capital Research Global Investors](/funds/1422848.md) | 2026-06-30 | $343.0m | 3,367,530 |  | Reduced −286,408 |
| [VANGUARD PORTFOLIO MANAGEMENT LLC](/funds/2100121.md) | 2026-06-30 | $330.2m | 3,241,880 |  | Added +156,605 |
| [Jupiter Topco LLC](/funds/2146052.md) | 2026-06-30 | $309.9m | 3,042,429 |  | Not compared |
| [Durable Capital Partners LP](/funds/1798849.md) | 2026-06-30 | $299.2m | 2,937,488 |  | Reduced −354,028 |
| [JANUS HENDERSON GROUP PLC](/funds/1274173.md) | 2026-03-31 | $256.1m | 2,987,691 |  | Not compared |
| [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $232.2m | 2,279,148 |  | Added +734,579 |

## Recent filings

[All 552 filings](/companies/uls/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-01 | 20:11 ET | [8-K](/filings/0001628280-26-064246.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-26-064246 |
| 2026-08-04 | 21:24 ET | [10-Q](/filings/0001901440-26-000023.md) | Quarterly report, period 2026-06-30 | 0001901440-26-000023 |
| 2026-08-04 | 10:58 ET | [8-K](/filings/0001901440-26-000021.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001901440-26-000021 |
| 2026-06-03 | 20:13 ET | [8-K](/filings/0001901440-26-000019.md) | 5.02 Departure or appointment of officers or directors | 0001901440-26-000019 |
| 2026-05-22 | 16:57 ET | [8-K](/filings/0001901440-26-000015.md) | 5.07 Shareholder vote results | 0001901440-26-000015 |
| 2026-05-05 | 20:17 ET | [10-Q](/filings/0001901440-26-000012.md) | Quarterly report, period 2026-03-31 | 0001901440-26-000012 |
| 2026-05-05 | 11:02 ET | [8-K](/filings/0001901440-26-000009.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001901440-26-000009 |
| 2026-04-13 | 20:23 ET | [8-K](/filings/0001193125-26-152920.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-152920 |
| 2026-04-02 | 20:01 ET | [DEF 14A](/filings/0001193125-26-140022.md) | Proxy statement, period 2026-05-20 | 0001193125-26-140022 |
| 2026-02-19 | 21:23 ET | [10-K](/filings/0001901440-26-000005.md) | Annual report, period 2025-12-31 | 0001901440-26-000005 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001901440-26-000005.md), filed Feb 19, 2026.

## Forecast league

Q3 FY2026, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by \[object Promise\]. [Forecast this quarter](/leagues/2026q3/targets/aed1d689-22a8-46b9-99d9-1e69db8df3ff)

## About the filer

- CIK: 1901440
- Tickers: ULS
- Exchange: NYSE
- SIC code: 8734 Services-Testing Laboratories
- State of incorporation: DE
- Filer category: Large accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:49 ET. No prices; not investment advice.